The present invention relates to substituted tricyclic compounds, which can be used as vanilloid receptor ligands. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by vanilloid receptor-1 (VRl). Also provided herein are pharmaceutical compositions and methods for treating or preventing diseases, conditions and/or disorders modulated by VRl.
本发明涉及替代
三环化合物,可用作
辣椒素受体
配体。具体来说,本文描述的化合物可用于治疗或预防由
辣椒素受体-1(VR1)调节的疾病、症状和/或疾病。本文还提供了用于治疗或预防由VR1调节的疾病、症状和/或疾病的药物组合物和方法。